The Clinical Biomarkers & World CDx Europe Summit 2018 is focused on improving the development and clinical validation of biomarker signatures to better demonstrate efficacy for targeted therapeutics and accelerate the commercialisation of Dx-enabled precision medicines.
Our targeted summits bring together the multi-stakeholder network to accelerate the discovery, clinical development and patient access of biomarker-driven precision therapies.
From the biopharma perspective, the meeting brings together two communities:
For the insight and commercial relationships that build each and every year. Be part of the community that connects:
Tailored Opportunities include:
For further information please don’t hesitate to send us an email.